NASDAQ$PNTG

The Pennant Group Inc · Q2 2024 earnings

Q2 2024 earnings · · Investor relations

Briefing

Pennant Group reported strong second quarter results driven by solid performance in mature operations and acquisition activity.

Pennant Group reported a strong second quarter with a 27.6% increase in total revenue to $168.7 million, and a 103.4% increase in net income to $5.7 million. The company is updating its annual guidance based on sustainable momentum and accretive additions.

  • Total revenue increased by 27.6% year-over-year to $168.7 million.
  • Net income increased by 103.4% year-over-year to $5.7 million.
  • Home Health and Hospice Services segment revenue increased by 31.9% year-over-year to $125.3 million.
  • Senior Living Services segment revenue increased by 16.6% year-over-year to $43.4 million.

Headline financials

Total Revenue

$169M

Previous: $132M+27.6%
EPS

$0.18

Previous: $0.18+0.0%
Total Hospice Admissions

3.1K

No prior period
Total Home Health Admissions

14.1K

Previous: 10.4K+35.4%
Medicare HH Admissions

5.7K

Previous: 4.8K+18.3%
Avg Medicare Rev per Episode

$3.67K

No prior period
Hospice Avg Daily Census

3.2K

Previous: 2.5K+29.1%
Hospice Medicare Rev per Day

$184.00

No prior period
Senior Living Occupancy

78.8%

No prior period
Avg Monthly Rev per Unit

$4.79K

No prior period
Capital Expenditures

-$4.76M

Previous: -$3.97M-19.9%
Free Cash Flow

$928K

Previous: -$1.18M+178.9%
Net Income

$5.69M

Previous: $2.8M+103.4%
Operating Income

$9.56M

Previous: $6.26M+52.7%
Gross Profit

-$135M

Previous: -$106M-27.4%
Cash & Equivalents

$3.04M

Previous: $2.84M+7.2%
Total Assets

$602M

Previous: $515M+16.9%
Stock-Based Comp

$1.85M

Previous: $1.3M+42.1%

Revenue & EPS history

Pennant Group · Revenue · Quarterly

$169M

Q2 2024+27.6%vs Q2 2023
Beat estimate in 12 of 14 quarters(86%)
ActualEstimate

Revenue by segment

Pennant Group · $37.3M total across 1 segment · Q2 2023

  • Senior Living Services
    $37.3M

Forward guidance

Management is updating its annual guidance as follows: total revenue is anticipated to be between $654.0 million and $694.5 million; full year 2024 adjusted earnings per diluted share is anticipated to be between $0.89 and $0.95; and full year 2024 adjusted EBITDA is anticipated to be between $50.7 million and $53.8 million.

Tailwinds

  • Total revenue is anticipated to be between $654.0 million and $694.5 million.
  • Full year 2024 adjusted earnings per diluted share is anticipated to be between $0.89 and $0.95.
  • Full year 2024 adjusted EBITDA is anticipated to be between $50.7 million and $53.8 million.
  • Guidance incorporates current operations and organic growth.
  • It anticipates continued strong operating performance through the end of the year.

Headwinds

  • Hospice reimbursement rate adjustments.
  • Increased interest expense.
  • Excludes unannounced acquisitions.
  • Excludes the announced purchase of Signature’s Oregon assets.
  • Excludes share-based compensation, acquisition-related costs, or one-time implementation and unusual items.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2024

Historical avgQ2 2024

-0.4%

Avg return

Earnings day

+5.0%

Avg return

5 days after

+5.6%

Avg return

30 days after

40%

12 / 30 earnings

Positive

+27.4%

Q2 2020

Best reaction

-18.7%

Q3 2021

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+3.4%+8.4%+0.5%
Q4 2025-7.8%-0.2%-9.8%
Q3 2025-5.8%+0.4%+16.1%
Q1 2025+3.7%+10.1%+10.1%
Q4 2024-10.8%-8.1%-3.6%
Q3 2024+0.6%+6.4%-5.9%
Q2 2024+0.3%+8.2%+18.3%
Q1 2024-2.3%+5.8%+11.3%
Q4 2023+12.4%+13.3%+18.3%
Q3 2023+7.6%+5.7%+13.6%
Q2 2023-1.2%+8.9%+1.3%
Q1 2023-9.4%-14.7%-6.8%
Q4 2022+11.3%+20.7%+8.9%
Q3 2022-11.4%-10.8%-20.0%
Q2 2022+6.8%+12.6%+0.6%
Q1 2022+6.6%+26.4%+21.3%
Q4 2021-7.5%-7.9%+12.9%
Q3 2021-18.7%-6.9%-21.1%
Q2 2021-5.8%-15.0%+0.0%
Q1 2021-2.2%-9.4%-14.2%
Q4 2020-8.3%-7.5%-16.9%
Q3 2020-0.5%+5.3%+21.1%
Q2 2020+27.4%+23.8%+15.9%
Q1 2019+15.1%+51.2%+45.5%
Q1 2020+15.1%+51.2%+45.5%
Q2 2019-3.3%-13.7%-43.7%
Q4 2017-3.3%-13.7%-43.7%
Q4 2019-3.3%-13.7%-43.7%
Q3 2019-10.5%+7.0%+68.4%
Q4 2018-10.5%+7.0%+68.4%
Q3 2018
Q2 2018
Q1 2018

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro